Northwestern: 'Xolair is a Tremendous Breakthrough for Severe Food Allergy Treatment'
February 20, 2024
February 20, 2024
CHICAGO, Illinois, Feb. 20 -- Northwestern University issued the following news release:
Food allergy expert, Dr. Ruchi Gupta, is available to comment on the U.S. Food and Drug Administration's approval of the asthma drug Xolair to treat severe food allergies.
Dr. Gupta is the director of the Center for Food Allergy & Asthma and a professor of pediatrics at Northwestern University Feinberg School of Medicine.
"This is a tremendous breakthrough . . .
Food allergy expert, Dr. Ruchi Gupta, is available to comment on the U.S. Food and Drug Administration's approval of the asthma drug Xolair to treat severe food allergies.
Dr. Gupta is the director of the Center for Food Allergy & Asthma and a professor of pediatrics at Northwestern University Feinberg School of Medicine.
"This is a tremendous breakthrough . . .